• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白蛋白在肝细胞癌生长抑制中的作用

Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma.

作者信息

Bağırsakçı Ezgi, Şahin Eren, Atabey Neşe, Erdal Esra, Guerra Vito, Carr Brian I

机构信息

Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey.

出版信息

Oncology. 2017;93(2):136-142. doi: 10.1159/000471807. Epub 2017 May 10.

DOI:10.1159/000471807
PMID:28486226
Abstract

OBJECTIVE

Levels of serum albumin have recently emerged, together with C-reactive protein, as an important prognostic indicator for hepatocellular carcinoma (HCC). It has recently been reported that larger HCCs are associated with lower albumin levels. However, the albumin-mediated growth decrease has yet to be determined.

METHODS

We examined a large HCC cohort and then by direct exposure of HCC cells in vitro, the relationship of albumin levels to HCC growth.

RESULTS

We found that patients with lower albumin levels had significantly larger maximum tumor diameters, more portal vein thrombosis, more tumor multifocality, higher α-fetoprotein levels, and a lower survival than patients with higher albumin levels. Direct addition of exogenous albumin at physiological concentrations resulted in decreased growth in several HCC cell lines in vitro. We found a decrease in MAP kinase levels and in levels of Cdk2 and Cdk4, cyclinE, as well as in α-fetoprotein.

CONCLUSION

These results indicate that in addition to its role as a monitor of systemic inflammation, albumin may have a direct role in HCC growth inhibition, either through modulation of α-fetoprotein or through its actions on growth-controlling kinases.

摘要

目的

血清白蛋白水平最近与C反应蛋白一起,成为肝细胞癌(HCC)的重要预后指标。最近有报道称,较大的肝癌与较低的白蛋白水平相关。然而,白蛋白介导的生长抑制作用尚未确定。

方法

我们研究了一个大型肝癌队列,然后通过体外直接暴露肝癌细胞,研究白蛋白水平与肝癌生长的关系。

结果

我们发现,白蛋白水平较低的患者与白蛋白水平较高的患者相比,最大肿瘤直径明显更大,门静脉血栓形成更多,肿瘤多灶性更多,甲胎蛋白水平更高,生存率更低。在生理浓度下直接添加外源性白蛋白导致几种肝癌细胞系在体外生长减少。我们发现丝裂原活化蛋白激酶水平以及细胞周期蛋白依赖性激酶2(Cdk2)、细胞周期蛋白依赖性激酶4(Cdk4)、细胞周期蛋白E以及甲胎蛋白水平均下降。

结论

这些结果表明,除了作为全身炎症的监测指标外,白蛋白可能通过调节甲胎蛋白或通过其对生长控制激酶的作用,在肝癌生长抑制中发挥直接作用。

相似文献

1
Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma.白蛋白在肝细胞癌生长抑制中的作用
Oncology. 2017;93(2):136-142. doi: 10.1159/000471807. Epub 2017 May 10.
2
Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.肝细胞癌患者血清白蛋白水平与肿瘤参数的关系
Int J Biol Markers. 2017 Oct 31;32(4):e391-e396. doi: 10.5301/ijbm.5000300.
3
Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.甲胎蛋白和白蛋白基因在人肝细胞癌中的表达:基因治疗中这些基因用于靶向人肝细胞癌的应用局限性。
Hepatology. 1998 Feb;27(2):599-607. doi: 10.1002/hep.510270239.
4
Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.土耳其患者肝细胞癌侵袭性因素的特征
Oncology. 2018;94(2):116-124. doi: 10.1159/000484564. Epub 2017 Dec 6.
5
Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.肝癌侵袭性指标的相关性研究。
J Gastrointest Cancer. 2021 Dec;52(4):1340-1349. doi: 10.1007/s12029-021-00720-z. Epub 2021 Oct 6.
6
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.一种在肝细胞癌中上调的新型预后生物标志物SPC24。
Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.
7
Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.手术切除的小肝细胞癌中甲胎蛋白及维生素K缺乏或拮抗剂II诱导蛋白表达的免疫组织学研究
Hepatology. 2001 Dec;34(6):1128-34. doi: 10.1053/jhep.2001.29202.
8
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.低甲胎蛋白水平与门静脉血栓形成的肝细胞癌患者生存率提高相关。
Dig Dis Sci. 2016 Mar;61(3):937-47. doi: 10.1007/s10620-015-3922-3. Epub 2015 Nov 17.
9
MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.MUC15 抑制 EGFR 二聚化和 PI3K-AKT 信号通路,与患者侵袭性肝细胞癌相关。
Gastroenterology. 2013 Dec;145(6):1436-48.e1-12. doi: 10.1053/j.gastro.2013.08.009. Epub 2013 Aug 9.
10
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.肝癌患者甲胎蛋白水平的决定因素:对其临床应用的影响。
Cancer. 2014 Jul 15;120(14):2150-7. doi: 10.1002/cncr.28706. Epub 2014 Apr 10.

引用本文的文献

1
Analysis of the optimal patterns of serum alpha fetoprotein (AFP), AFP-L3% and protein induced by vitamin K absence or antagonist-II (PIVKA-II) detection in the diagnosis of liver cancers.血清甲胎蛋白(AFP)、甲胎蛋白异质体-L3%(AFP-L3%)及维生素K缺乏或拮抗剂-II诱导蛋白(PIVKA-II)检测在肝癌诊断中的最佳模式分析
PeerJ. 2025 Jul 21;13:e19712. doi: 10.7717/peerj.19712. eCollection 2025.
2
Association of albumin-bilirubin grade with survival outcomes in patients with cholangiocarcinoma.白蛋白-胆红素分级与胆管癌患者生存结局的关联
PLoS One. 2025 May 7;20(5):e0321758. doi: 10.1371/journal.pone.0321758. eCollection 2025.
3
Factors Relating to Tumor Size and Survival in Patients with Hepatocellular Carcinoma: Significance of Platelet-Lymphocyte Ratio, Portal Vein Thrombosis, and Albumin.
肝细胞癌患者肿瘤大小与生存的相关因素:血小板-淋巴细胞比值、门静脉血栓形成及白蛋白的意义
Oncology. 2025 Apr 8:1-11. doi: 10.1159/000545636.
4
Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients.乙肝患者根治性切除术后肝细胞癌的机器学习预后模型
J Hepatocell Carcinoma. 2025 Feb 19;12:353-365. doi: 10.2147/JHC.S495059. eCollection 2025.
5
The Red Cell Distribution Width to Albumin Ratio: A Novel Prognostic Indicator in Hepatitis B Virus-Related Hepatocellular Carcinoma.红细胞分布宽度与白蛋白比值:乙肝病毒相关肝细胞癌的一种新型预后指标
Int J Med Sci. 2025 Jan 1;22(2):441-450. doi: 10.7150/ijms.103125. eCollection 2025.
6
Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment.基于γ-谷氨酰转移酶与白蛋白比值的列线图模型预测接受经动脉化疗栓塞治疗的肝细胞癌患者的生存情况。
World J Gastrointest Oncol. 2024 Dec 15;16(12):4650-4662. doi: 10.4251/wjgo.v16.i12.4650.
7
Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival.伴有门静脉血栓形成的肝癌患者的特征:白蛋白与生存情况。
Oncology. 2024 Dec 9:1-10. doi: 10.1159/000542774.
8
Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model.TACE联合消融治疗的低白蛋白-胆红素分级患者肝细胞癌的复发:随机森林Cox预测模型
J Hepatocell Carcinoma. 2024 Jul 8;11:1375-1388. doi: 10.2147/JHC.S465962. eCollection 2024.
9
Prognostic significance of platelet‑to‑albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases.血小板-白蛋白比值对接受同期放化疗的鼻咽癌患者预后的意义:858 例回顾性研究。
BMC Cancer. 2024 Jun 25;24(1):762. doi: 10.1186/s12885-024-12499-w.
10
Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma.预测老年肝细胞癌患者手术切除后总生存期和无病生存期的列线图的开发与验证
Front Oncol. 2024 May 24;14:1395740. doi: 10.3389/fonc.2024.1395740. eCollection 2024.